INTRODUCTION Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) have been circulating worldwide since the beginning of the pandemic. Some are termed …

The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 and
SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against …

The need for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) next-
generation vaccines has been highlighted by the rise of variants of concern (VoCs) and the …

The COVID-19 pandemic has increased demand for safe and effective vaccines. Research
to develop vaccines against diseases including Middle East respiratory syndrome …

Emergence of novel variants of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) underscores the need for next-generation vaccines able to elicit broad and durable …

SARS-CoV in 2003, SARS-CoV-2 in 2019, and SARS-CoV-2 variants of concern (VOC) can
cause deadly infections, underlining the importance of develo** broadly effective …

The emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants stresses the continued need for next-generation vaccines that confer broad …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be expanding
the pandemic disease across the globe. Although SARS-CoV-2 vaccines were rapidly …

The emergence of SARS-CoV-2 variants, especially Beta and Delta, has raised concerns
about the reduced protection from previous infection or vaccination based on the original …

Development of affordable and effective vaccines that can also protect vulnerable
populations such as the elderly from COVID-19-related morbidity and mortality is a public …